Page 45 - Read Online

Strassheim et al. Vessel Plus 2018;2:29 I http://dx.doi.org/10.20517/2574-1209.2018.44 Page 17 of 22

112. Shang P, He ZY, Chen JF, Huang SY, Liu BH, Liu HX, Wang XT. Absence of the Adenosine A2A receptor confers pulmonary arterial
hypertension through RhoA/ROCK signaling pathway in mice. J Cardiovasc Pharmacol 2015;66:569-75.
113. Singh NK, Janjanam J, Rao GN. p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine-induced vascular
smooth muscle cell migration and proliferation. J Biol Chem 2017;292:14080-91.
114. Norton CE, Broughton BR, Jernigan NL, Walker BR, Resta TC. Enhanced depolarization-induced pulmonary vasoconstriction
following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2. Antioxid Redox Signal 2013;18:1777-88.
115. Wang Y, Xu X, Pan M, Jin T. ELMO1 directly interacts with gbetagamma subunit to transduce GPCR signaling to Rac1 activation in
chemotaxis. J Cancer 2016;7:973-83.
116. Nguyen Dinh Cat A, Montezano AC, Burger D, Touyz RM. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.
Antioxid Redox Signal 2013;19:1110-20.
117. Li Y, Pagano PJ. Microvascular NADPH oxidase in health and disease. Free Radic Biol Med 2017;109:33-47.
118. Rastogi R, Geng X, Li F, Ding Y. NOX activation by subunit interaction and underlying mechanisms in disease. Front Cell Neurosci
2016;10:301.
119. Paulsen CE, Carroll KS. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem Rev 2013;113:4633-79.
120. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, Semenza GL. Impaired
physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 1999;103:691-
6.
121. Tan Q, Kerestes H, Percy MJ, Pietrofesa R, Chen L, Khurana TS, Christofidou-Solomidou M, Lappin TR, Lee FS. Erythrocytosis and
pulmonary hypertension in a mouse model of human HIF2A gain of function mutation. J Biol Chem 2013;288:17134-44.
122. Zhang L, Xiong W, Li N, Liu H, He H, Du Y, Zhang Z, Liu Y. Estrogen stabilizes hypoxia-inducible factor 1alpha through G protein-
coupled estrogen receptor 1 in eutopic endometrium of endometriosis. Fertil Steril 2017;107:439-47.
123. Li M, Liu Y, Jin F, Sun X, Li Z, Liu Y, Fang P, Shi H, Jiang X. Endothelin-1 induces hypoxia inducible factor 1alpha expression in
pulmonary artery smooth muscle cells. FEBS Lett 2012;586:3888-93.
124. De Francesco EM, Pellegrino M, Santolla MF, Lappano R, Ricchio E, Abonante S, Maggiolini M. GPER mediates activation of
HIF1alpha/VEGF signaling by estrogens. Cancer Res 2014;74:4053-64.
125. Ji R, Chou CL, Xu W, Chen XB, Woodward DF, Regan JW. EP1 prostanoid receptor coupling to G i/o up-regulates the expression of
hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathway. Mol Pharmacol 2010;77:1025-
36.
126. Kasama H, Sakamoto Y, Kasamatsu A, Okamoto A, Koyama T, Minakawa Y, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
Adenosine A2b receptor promotes progression of human oral cancer. BMC Cancer 2015;15:563.
127. Lee SJ, No YR, Dang DT, Dang LH, Yang VW, Shim H, Yun CC. Regulation of hypoxia-inducible factor 1alpha (HIF-1alpha) by
lysophosphatidic acid is dependent on interplay between p53 and Kruppel-like factor 5. J Biol Chem 2013;288:25244-53.
128. Lee HY, Lee T, Lee N, Yang EG, Lee C, Lee J, Moon EY, Ha J, Park H. Src activates HIF-1alpha not through direct phosphorylation of
HIF-1alpha specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway. Carcinogenesis 2011;32:703-
12.
129. Du J, Xu R, Hu Z, Tian Y, Zhu Y, Gu L, Zhou L. PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1alpha
expression in MCF-7 breast cancer cells. PLoS One 2011;6:e25213.
130. Chang TC, Huang CJ, Tam K, Chen SF, Tan KT, Tsai MS, Lin TN, Shyue SK. Stabilization of hypoxia-inducible factor-1{alpha} by
prostacyclin under prolonged hypoxia via reducing reactive oxygen species level in endothelial cells. J Biol Chem 2005;280:36567-74.
131. Takabuchi S, Hirota K, Oda S, Nishi K, Oda T, Shingu K, Adachi T, Fukuda K. Opioid receptor stimulation does not affect cellular
hypoxia-induced gene responses mediated by hypoxia-inducible factor 1 in cultured cell lines. J Anesth 2005;19:263-5.
132. Griguer CE, Oliva CR, Kelley EE, Giles GI, Lancaster JR, Jr., Gillespie GY. Xanthine oxidase-dependent regulation of hypoxia-
inducible factor in cancer cells. Cancer Res 2006;66:2257-63.
133. Xia L, Mo P, Huang W, Zhang L, Wang Y, Zhu H, Tian D, Liu J, Chen Z, Zhang Y, Chen Z, Hu H, Fan D, Nie Y, Wu K. The TNF-
alpha/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis
2012;33:2250-9.
134. Lee G, Won HS, Lee YM, Choi JW, Oh TI, Jang JH, Choi DK, Lim BO, Kim YJ, Park JW, Puigserver P, Lim JH. Oxidative
dimerization of PHD2 is responsible for its inactivation and contributes to metabolic reprogramming via HIF-1alpha activation. Sci Rep
2016;6:18928.
135. Fukai K, Nakamura A, Hoshino A, Nakanishi N, Okawa Y, Ariyoshi M, Kaimoto S, Uchihashi M, Ono K, Tateishi S, Ikeda K, Ogata
T, Ueyama T, Matoba S. Pyk2 aggravates hypoxia-induced pulmonary hypertension by activating HIF-1alpha. Am J Physiol Heart Circ
Physiol 2015;308:H951-9.
136. Yang T, Li ZN, Chen G, Gu Q, Ni XH, Zhao ZH, Ye J, Meng XM, Liu ZH, Xiong CM, He JG. Increased levels of plasma CXC-
chemokine ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial
hypertension. Heart Lung 2014;43:322-7.
137. McCullagh BN, Costello CM, Li L, O’Connell C, Codd M, Lawrie A, Morton A, Kiely DG, Condliffe R, Elliot C, McLoughlin P, Gaine S.
Elevated plasma CXCL12alpha is associated with a poorer prognosis in pulmonary arterial hypertension. PLoS One 2015;10:e0123709.
138. Kazimierczyk R, Blaszczak P, Jasiewicz M, Knapp M, Ptaszynska-Kopczynska K, Sobkowicz B, Waszkiewicz E, Grzywna R, Musial
WJ, Kaminski KA. Increased platelet content of SDF-1alpha is associated with worse prognosis in patients with pulmonary arterial
hypertension. Platelets 2018; doi: 10.1080/09537104.2018.1457780.